Anemia and morbidity and mortality in coronary bypass surgery

Current Opinion in Anaesthesiology

Volumn 20, Issue 1, 2007, Pages 57-64

  Kulier, Alexander ^a,b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Anemia; Coronary artery bypass grafting surgery; Coronary artery disease; Hemoglobin; Myocardial infarction; Transfusion

Indexed keywords

HEMOGLOBIN;

ANEMIA; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; COMORBIDITY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CRITICAL ILLNESS; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SURGICAL RISK; TRANSFUSION;

ANEMIA; BLOOD TRANSFUSION; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; HUMANS; INTRAOPERATIVE COMPLICATIONS; KIDNEY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK;

EID: 33846040312     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328013da20     Document Type: Review

References (77)

1. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA 1999; 281:1714-1717.
2. Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Curr Opin Hematol 2005; 12:123-128. Review on the occurrence of anemia in older persons and its association with increased morbidity and mortality, hospitalization, physical decline, and disability.
3. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104:2263-2268.
4. Penninx BW, Guralnik JM, Onder G, et al. Anemia and decline in physical performance among older persons. Am J Med 2003; 115:104-110.
5. Ble A, Fink JC, Woodman RC, et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med 2005; 165:2222-2227.
6. Ania BJ, Suman VJ, Fairbanks VF, et al. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc 1997; 45:825-831.
7. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J 1994; 127:674-682.
8. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507.
9. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004; 32:39-52.
10. Kulier A, Gombotz H. Perioperative anemia. Anaesthesist 2001; 50:73-86.
11. Spence RK, Carson JA, Poses R, et al. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990; 159:320-324.
12. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993; 21:860-866.
13. Ferraris VA, Ferraris SP. Risk factors for postoperative morbidity. J Thorac Cardiovasc Surg 1996; 111:731-738; discussion 738-741.
14. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055-1060.
15. Fang WC, Helm RE, Krieger KH, et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997; 96:II-194-II-199.
16. Carson JL, Duff A, Berlin JA, et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998; 279:199-205.
17. Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002; 359:1747-1748.
18. Rady MY, Ryan T, Starr NJ. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 1998; 26:225-235.
19. Spiess BD, Ley C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg 1998; 116:460-467.
20. Hogue CW Jr, Goodnough LT, Monk TG. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 1998; 38:924-931.
21. Gruson KI, Aharonoff GB, Egol KA, et al. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 2002; 16:39-44.
22. Dunne JR, Malone D, Tracy JK, et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002; 102:237-244.
23. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42:812-818.
24. Dunne JR, Gannon CJ, Osborn TM, et al. Preoperative anemia in colon cancer: assessment of risk factors. Am Surg 2002; 68:582-587.
25. Shander A, Knight K, Thurer R, et al. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 5:58S-69S.
26. Magovern JA, Sakert T, Magovern GJ, et al. A model that predicts morbidity and mortality after coronary artery bypass graft surgery. J Am Coll Cardiol 1996; 28:1147-1153.
27. Habib RH, Zacharias A, Schwann TA, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 2003; 125:1438-1450.
28. DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001; 71:769-776.
29. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing CABG surgery. Circulation 2006; submitted.
30. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998; 88:327-333.
31. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006; 113:2454-2461. Comprehensive epidemiological review of anemia in patients with chronic heart failure, including prevalence and etiology.
32. Chaves PH, Semba RD, Leng SX, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 2005; 60:729-735.
33. Horl WH, Ertl G. Anaemia and the heart. Eur J Clin Invest 2005; 35 (Suppl 3):20-25. Review describing prevalence, risk and association with morbidity and mortality of anemia in patients with congestive heart failure, acute myocardial infarction, and those undergoing heart surgery or percutaneous coronary interventions.
34. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107:223-225.
35. Berry C, Hogg K, Norrie J, et al. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart 2005; 91:907-913.
36. Katz SD, Maskin C, Jondeau G, et al. Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol 2000; 88:2138-2142.
37. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279:217-221.
38. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000; 92:1646-1652.
39. Spahn DR, Zollinger A, Schlumpf RB, et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 1996; 82:681-686.
40. Nappi J. Anemia in patients with coronary artery disease. Am J Health Syst Pharm 2003; 60:S4-S8.
41. Spahn DR, Smith LR, Schell RM, et al. Importance of severity of coronary artery disease for the tolerance to normovolemic hemodilution. Comparison of single-vessel versus multivessel stenoses in a canine model. J Thorac Cardiovasc Surg 1994; 108:231-239.
42. Levy PS, Quigley RL, Gould SA. Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma 1996; 41:416-423.
43. Greenburg AG. A physiologic basis for red blood cell transfusion decisions. Am J Surg 1995; 170:44S-48S.
44. Doak GJ, Hall RI. Does hemoglobin concentration affect perioperative myocardial lactate flux in patients undergoing coronary artery bypass surgery? Anesth Analg 1995; 80:910-916.
45. Spahn DR, Schmid ER, Seifert B, Pasch T. Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 1996; 82:687-694.
46. Spahn DR, Seifert B, Pasch T, Schmid ER. Haemodilution tolerance in patients with mitral regurgitation. Anaesthesia 1998; 53:20-24.
47. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999; 39:1070-1077.
48. Spahn DR, Dettori N, Kocian R, Chassot PG. Transfusion in the cardiac patient. Crit Care Clin 2004; 20:269-279.
49. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345:1230-1236.
50. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292:1555-1562. In more than 24 000 patients with acute coronary syndromes enrolled in 3 international trials, blood transfusion was associated with higher mortality.
51. Lipsic E, van der Horst IC, Voors AA, et al. Hemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol 2005; 100:289-292. Retrospective study on 1841 consecutive patients admitted with the diagnosis of acute MI finding that lower levels of hemoglobin were independently associated with higher 30-day mortality.
52. Al Falluji N, Lawrence-Nelson J, Kostis JB, et al. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002; 144:636-641.
53. Koch CG, Weng YS, Zhou SX, et al. Prevalence of risk factors, and not gender per se, determines short- and long-term survival after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2003; 17:585-593.
54. Nashef SA, Roques F, Hammill BG, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002; 22:101-105.
55. Karkouti K, Beattie WS, Wijeysundera DN, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 2005; 129:391-400. In patients undergoing cardiac surgery, there was an independent, nonlinear relationship between nadir hematocrit concentration during cardiopulmonary bypass and acute renal failure necessitating dialysis support.
56. Habib RH, Zacharias A, Schwann TA, Riordan CJ. The independent effects of cardiopulmonary bypass hemodilutional anemia and transfusions on CABG outcomes. Eur J Cardiothorac Surg 2005;28:512-513; author reply 513-514.
57. Habib RH, Zacharias A, Schwann TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005; 33:1749-1756. In patients undergoing cardiopulmonary bypass, intraoperative hemodilution to hematocrit <24% was associated with a systematically increased likelihood of renal injury and consequently worse operative outcomes.
58. Surgenor SD, DeFoe GR, Fillinger MP, et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006; 114:I43-I48. Study on 8004 patients undergoing isolated CABG surgery finding that exposure to both hemodilutional anemia and RBC transfusion during surgery were associated with increased risk of postoperative low cardiac output state.
59. von Heymann C, Sander M, Foer A, et al. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome: a randomized controlled study [ISRCTN35655335]. Crit Care 2006; 10:R58.
60. Hardy JF, Martineau R, Couturier A, et al. Influence of haemoglobin concentration after extracorporeal circulation on mortality and morbidity in patients undergoing cardiac surgery. Br J Anaesth 1998; 81 (Suppl 1):38-45.
61. Freudenberger RS, Carson JL. Is there an optimal hemoglobin value in the cardiac intensive care unit? Curr Opin Crit Care 2003; 9:356-361.
62. Johnson RG, Thurer RL, Kruskall MS, et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992; 104:307-314.
63. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417.
64. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29:227-234.
65. Valeri CR, Dennis RC, Ragno G, et al. Limitations of the hematocrit level to assess the need for red blood cell transfusion in hypovolemic anemic patients. Transfusion 2006; 46:365-371.
66. Koch CG, Khandwala F, Li L, et al. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 2006; 82:13-20.
67. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34:1608-1616. Study on 11 963 patients undergoing coronary artery bypass graft surgery finding that perioperative red blood cell transfusion was the single factor most reliably associated with increased risk of postoperative morbid events, with an incrementally increased risk for each transfusion unit administered.
68. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81:1650-1657. Social Security Index analysis in >10 000 patients undergoing coronary artery bypass graft surgery finding that perioperative PRBC transfusion was associated with increased long-term mortality.
69. Vamvakas EC, Carven JH. RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: the effects of confounding factors. Transfusion 2000; 40:832-839.
70. Kuduvalli M, Oo AY, Newall N, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 2005; 27:592-598.
71. Chelemer SB, Prato BS, Cox PM Jr, et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002; 73:138-142.
72. Kulier AH, Gombotz H, Fuchs G, et al. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. Anesth Analg 1993; 76:102-106.
73. Kulier A, Gombotz H, Stubenvoll E. Erythropoietin in patients undergoing coronary artery bypass graft surgery. Clin Invest 1994; 72:S19-S24.
74. Mazzarella V, Gallucci MT, Tozzo C, et al. Renal function in patients undergoing cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1992; 104:1625-1627.
75. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128:194-203.
76. Gleissner CA, Murat A, Schafer S, et al. Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function. Transplantation 2004; 77:710-717.
77. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38:955-962.